Protagenic Therapeutics (PTIX) Short Interest Ratio & Short Volume

-0.04 (-3.10%)
(As of 04/22/2024 ET)

Protagenic Therapeutics Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
Short Interest Ratio / Days to Cover
Last Record Date
March 31, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Protagenic Therapeutics ?

Sign up to receive the latest short interest report for Protagenic Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PTIX Short Interest Over Time

PTIX Days to Cover Over Time

PTIX Percentage of Float Shorted Over Time

Protagenic Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202411,300 shares $19,775.00 -7.4%0.3%1.1 $1.75
3/15/202412,200 shares $14,030.00 +32.6%0.3%1.3 $1.15
2/29/20249,200 shares $9,660.00 -6.1%0.3%1.1 $1.05
2/15/20249,800 shares $9,457.00 -31.0%0.3%1.4 $0.97
1/31/202414,200 shares $13,490.00 No Change0.4%2.4 $0.95
11/15/20239,200 shares $7,866.00 -6.1%0.3%0.7 $0.86
10/31/20239,800 shares $7,614.60 +988.9%0.3%0.7 $0.78
10/15/2023900 shares $755.10 -81.6%0.0%0.1 $0.84
9/30/20234,900 shares $9,016.00 +69.0%0.1%0.4 $1.84
9/15/20232,900 shares $5,046.00 +107.1%0.1%0.7 $1.74
8/31/20231,400 shares $2,660.00 +16.7%0.0%0.4 $1.90
2/12/2021100 shares $414.00 No ChangeN/A1 $4.14
1/29/2021100 shares $415.00 No ChangeN/A0.1 $4.15
9/30/2020100 shares $122.00 No ChangeN/A1 $1.22
9/15/2020100 shares $117.00 No ChangeN/A1 $1.17
8/31/2020100 shares $117.00 No ChangeN/A1 $1.17
8/14/2020100 shares $117.00 No ChangeN/A1 $1.17
7/31/2020100 shares $117.00 No ChangeN/A1 $1.17
7/15/2020100 shares $117.00 No ChangeN/A1 $1.17
6/30/2020100 shares $117.00 No ChangeN/A1 $1.17
6/15/2020100 shares $115.00 No ChangeN/A1 $1.15
5/29/2020100 shares $125.00 No ChangeN/A1 $1.25
5/15/2020100 shares $125.00 No ChangeN/A1 $1.25
4/30/2020100 shares $125.00 No ChangeN/A1 $1.25
4/15/2020100 shares $125.00 No ChangeN/A1 $1.25
3/31/2020100 shares $116.00 No ChangeN/A0.5 $1.16
3/13/2020100 shares $162.00 No ChangeN/A1 $1.62
2/28/2020100 shares $141.01 No ChangeN/A1 $1.41
2/14/2020100 shares $141.01 No ChangeN/A1 $1.41
1/31/2020100 shares $141.01 No ChangeN/A1 $1.41
1/15/2020100 shares $141.01 No ChangeN/A1 $1.41
12/31/2019100 shares $380.00 No ChangeN/A1 $3.80

PTIX Short Interest - Frequently Asked Questions

What is Protagenic Therapeutics' current short interest?

Short interest is the volume of Protagenic Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 11,300 shares of PTIX short. 0.32% of Protagenic Therapeutics' shares are currently sold short. Learn More on Protagenic Therapeutics' current short interest.

What is a good short interest ratio for Protagenic Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTIX shares currently have a short interest ratio of 1.0. Learn More on Protagenic Therapeutics's short interest ratio.

What is a good short interest percentage for Protagenic Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of Protagenic Therapeutics' floating shares are currently sold short.

Is Protagenic Therapeutics' short interest increasing or decreasing?

Protagenic Therapeutics saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 11,300 shares, a decline of 7.4% from the previous total of 12,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Protagenic Therapeutics' float size?

Protagenic Therapeutics currently has issued a total of 4,440,000 shares. Some of Protagenic Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Protagenic Therapeutics currently has a public float of 3,550,000 shares.

How does Protagenic Therapeutics' short interest compare to its competitors?

0.32% of Protagenic Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Protagenic Therapeutics: Hoth Therapeutics, Inc. (5.00%), Vaccinex, Inc. (1.17%), First Wave BioPharma, Inc. (3.04%), Avenue Therapeutics, Inc. (0.64%), Xenetic Biosciences Inc (0.14%), Cadrenal Therapeutics, Inc. (0.50%), Ainos, Inc. (4.81%), Oragenics, Inc. (2.07%), Shuttle Pharmaceuticals Holdings, Inc. (0.72%), Exicure, Inc. (2.40%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Protagenic Therapeutics stock?

Short selling PTIX is an investing strategy that aims to generate trading profit from Protagenic Therapeutics as its price is falling. PTIX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Protagenic Therapeutics?

A short squeeze for Protagenic Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTIX, which in turn drives the price of the stock up even further.

How often is Protagenic Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTIX, twice per month. The most recent reporting period available is March, 31 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:PTIX) was last updated on 4/23/2024 by Staff

From Our Partners